- Home
- OVID
as 02-21-2025 12:41pm EST
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 47.1M | IPO Year: | 2017 |
| Target Price: | $4.03 | AVG Volume (30 days): | 462.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.46 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.56 - $3.79 | Next Earning Date: | 03-07-2025 |
| Revenue: | $631,695 | Revenue Growth: | 113.21% |
| Revenue Growth (this year): | 71.38% | Revenue Growth (next year): | -44.16% |
Stock Insider Trading Activity of Ovid Therapeutics Inc. (OVID)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| ALEXANDER MARGARET A. | OVID | President and COO | Jan 27 '25 | Buy | $0.73 | 6,810 | $4,971.30 | 34,935 |
Latest Ovid Therapeutics Inc. News
OVID Breaking Stock News: Dive into OVID Ticker-Specific Updates for Smart Investing
GlobeNewswire
16 days ago
Ovid Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
TipRanks
22 days ago
Ovid Therapeutics upgraded at Oppenheimer as OV329’s promise ‘quite real’
Argus Research
22 days ago
Daily – Vickers Top Buyers & Sellers for 01/30/2025
Simply Wall St.
23 days ago
US Penny Stocks To Watch In January 2025
MT Newswires
23 days ago
Oppenheimer Upgrades Ovid Therapeutics to Outperform From Perform, $4 Price Target
Simply Wall St.
a month ago
Ovid Therapeutics Insider Ups Holding During Year
Simply Wall St.
2 months ago
3 US Penny Stocks With Market Caps Over $20M
GlobeNewswire
3 months ago
Ovid Therapeutics to Present Multiple Posters Supporting Its Pipeline Programs Targeting Neuronal Hyperexcitability at the American Epilepsy Society 2024 Annual Meeting
Compare OVID vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "OVID Ovid Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.